<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34727100</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Direct detection of polioviruses using a recombinant poliovirus receptor.</ArticleTitle><Pagination><StartPage>e0259099</StartPage><MedlinePgn>e0259099</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0259099</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0259099</ELocationID><Abstract><AbstractText>Polioviruses are positive-sense, single-stranded RNA picornaviruses and the principal cause of poliomyelitis. Global poliovirus surveillance has relied on poliovirus isolation in cells, which may take a minimum of 10 days, involves maintaining two cell lines, and propagates virus in high titers. With eradication underway, a major objective of the Global Polio Eradication Initiative (GPEI) is to develop culture-independent detection of polioviruses as an alternative method to complement the current virus isolation technique. A culture-independent method on poliovirus-positive stool suspensions was assessed with commercially available recombinant soluble poliovirus receptor (PVR) coupled to Histidine (His) tags. Viral RNA was screened by quantitative real-time reverse transcription PCR using the poliovirus intratypic differentiation kit. Poliovirus recovery was optimized with PVR-His-tagged protein and buffers supplemented with polyethylene glycol. To validate the poliovirus-PVR-His tag purification assay, 182 poliovirus-positive stools of programmatic importance were parallel tested against the GPLN-accepted virus isolation method. The PVR-His tag enrichment method detected poliovirus in 164 of 171 poliovirus-positive stools, whereas the virus isolation method misidentified 38 stools as poliovirus-negative (McNemar χ2 p&lt;0.0001). Using this method in combination with RNA extraction, viral RNA recovery increased and showed similar (WPV1) or higher (Sabin 1) sensitivity than the World Health Organization accredited variation of the virus isolation method. The PVR-His enrichment method could be a viable addition to poliovirus surveillance; similar methods have the potential to capture other human pathogens such as EV71 using an appropriate soluble His tag receptor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerloff</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5696-8318</Identifier><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelbaum</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cherokee Nation Assurance, Contracting Agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Nikail</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IHRC, Contracting agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Brittani</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>IHRC, Contracting agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Chelsea</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecker</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cherokee Nation Assurance, Contracting Agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agha</LastName><ForeName>Chadi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IHRC, Contracting agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Cara C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Everardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C066100">poliovirus receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="Y">Receptors, Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="Y">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>2</Day><Hour>17</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34727100</ArticleId><ArticleId IdType="pmc">PMC8562806</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0259099</ArticleId><ArticleId IdType="pii">PONE-D-21-08126</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mark A. Pallansch MSO, and Whitton J. Lindsay. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In: David M. Knipe PMH, editor. Fields Virology. 2. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; 2013.</Citation></Reference><Reference><Citation>WHO. Polio this week 2020 [updated 4/7/2020; cited 2020 4/20]. Case per week as of]. Available from: http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx.</Citation></Reference><Reference><Citation>WHO. Polio Eradication &amp; Endgame Strategic Plan 2013–2018. 2013.</Citation></Reference><Reference><Citation>WHO. Polio laboratory manual. 4th ed: WHO; 2004.</Citation></Reference><Reference><Citation>WHO. S1. Supplement to the WHO Polio Laboratory Manual: An alternative test algorithm for poliovirus isolation and characterization WHO; 2007 [updated Sep 2007; cited 2017]. Available from: https://polioeradication.org/wp-content/uploads/2017/05/NewAlgorithmForPoliovirusIsolationSupplement1.pdf.</Citation></Reference><Reference><Citation>Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S, et al.. Diagnostic Assay Development for Poliovirus Eradication. Journal of clinical microbiology. 2018;56(2). doi: 10.1128/JCM.01624-17 ; PubMed Central PMCID: PMC5786708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01624-17</ArticleId><ArticleId IdType="pmc">PMC5786708</ArticleId><ArticleId IdType="pubmed">29212703</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister RM, Melnyk J, Finklestein JZ, Adams EC, Gardner MB. Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer. 1969;24(3):520–6. doi: 10.1002/1097-0142(196909)24:3&lt;520::aid-cncr2820240313&gt;3.0.co;2-m</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(196909)24:3&lt;520::aid-cncr2820240313&gt;3.0.co;2-m</ArticleId><ArticleId IdType="pubmed">4241949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol. 1999;58(2):188–92. doi: 10.1002/(sici)1096-9071(199906)58:2&lt;188::aid-jmv15&gt;3.3.co;2-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1096-9071(199906)58:2&lt;188::aid-jmv15&gt;3.3.co;2-8</ArticleId><ArticleId IdType="pubmed">10335869</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO Global Action Plan to minimize poliovirus facility-associated risk after type-specific eradication of wild polioviruses and sequential cessation of oral polio vaccine use. Geneva: WHO, 2015 2015. Report No.</Citation></Reference><Reference><Citation>PAKISTAN POLIO UPDATE: Ministry of Health Pakistan; 2018 [updated June 2018]. Available from: http://www.endpolio.com.pk/media-room/pakistan-polio-update.</Citation></Reference><Reference><Citation>Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002;10(7):324–31. Epub 2002/07/12. doi: 10.1016/s0966-842x(02)02383-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0966-842x(02)02383-1</ArticleId><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell. 1989;56(5):855–65. 10.1016/0092-8674(89)90690-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90690-9</ArticleId><ArticleId IdType="pubmed">2538245</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbaszadegan M, Alum A, Abbaszadegan H, Stout V. Cell surface display of poliovirus receptor on Escherichia coli, a novel method for concentrating viral particles in water. Appl Environ Microbiol. 2011;77(15):5141–8. Epub 2011/05/31. doi: 10.1128/AEM.00071-11 ; PubMed Central PMCID: PMC3147470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.00071-11</ArticleId><ArticleId IdType="pmc">PMC3147470</ArticleId><ArticleId IdType="pubmed">21622793</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. Development of poliovirus extraction method from stool extracts by using magnetic nanoparticles sensitized with soluble poliovirus receptor. Journal of clinical microbiology. 2013;51(8):2717–20. doi: 10.1128/JCM.00499-13 ; PubMed Central PMCID: PMC3719659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00499-13</ArticleId><ArticleId IdType="pmc">PMC3719659</ArticleId><ArticleId IdType="pubmed">23698530</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Masujima S, Wakita T, Shimizu H. Development of a particle agglutination method with soluble virus receptor for identification of poliovirus. Journal of clinical microbiology. 2010;48(8):2698–702. Epub 2010/06/04. doi: 10.1128/JCM.00207-10 ; PubMed Central PMCID: PMC2916603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00207-10</ArticleId><ArticleId IdType="pmc">PMC2916603</ArticleId><ArticleId IdType="pubmed">20519462</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Kilpatrick DR, Nakamura T, Burns CC, Bukbuk D, Oderinde SB, et al.. Development of an efficient entire-capsid-coding-region amplification method for direct detection of poliovirus from stool extracts. Journal of clinical microbiology. 2015;53(1):73–8. doi: 10.1128/JCM.02384-14 ; PubMed Central PMCID: PMC4290957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02384-14</ArticleId><ArticleId IdType="pmc">PMC4290957</ArticleId><ArticleId IdType="pubmed">25339406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AG, Majumdar M, Troman C, O’Toole A, Benny B, Abraham D, et al.. Rapid and Sensitive Direct Detection and Identification of Poliovirus from Stool and Environmental Surveillance Samples by Use of Nanopore Sequencing. Journal of clinical microbiology. 2020;58(9). Epub 2020/07/03. doi: 10.1128/JCM.00920-20 ; PubMed Central PMCID: PMC7448630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00920-20</ArticleId><ArticleId IdType="pmc">PMC7448630</ArticleId><ArticleId IdType="pubmed">32611795</ArticleId></ArticleIdList></Reference><Reference><Citation>Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie. 1931;162(4):480–3. doi: 10.1007/bf01863914</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Ryan M, Bandyopadhyay AS, Villena R, Espinoza M, Novoa J, Weldon WC, et al.. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study. Lancet Infect Dis. 2015;15(11):1273–82. doi: 10.1016/S1473-3099(15)00219-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00219-4</ArticleId><ArticleId IdType="pubmed">26318714</ArticleId></ArticleIdList></Reference><Reference><Citation>Nottay BK, Kew OM, Hatch MH, Heyward JT, Obijeski JF. Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology. 1981;108(2):405–23. Epub 1981/01/30. doi: 10.1016/0042-6822(81)90448-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(81)90448-7</ArticleId><ArticleId IdType="pubmed">6258294</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. R: A Language and Environment for Statistical Computing. 3.3.1 ed. Vienna, Austria: R Foundation for Statistical Computing; 2016.</Citation></Reference><Reference><Citation>Petrie A, Sabin C. Medical Statistics at a Glance. Oxford: Blackwell Science Ltd; 2013.</Citation></Reference><Reference><Citation>Chen YH, Du W, Hagemeijer MC, Takvorian PM, Pau C, Cali A, et al.. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015;160(4):619–30. Epub 2015/02/14. doi: 10.1016/j.cell.2015.01.032 ; PubMed Central PMCID: PMC6704014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.032</ArticleId><ArticleId IdType="pmc">PMC6704014</ArticleId><ArticleId IdType="pubmed">25679758</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JE, Rossignol ED, Chang D, Zaia J, Forrester I, Raja K, et al.. Complexity and ultrastructure of infectious extracellular vesicles from cells infected by non-enveloped virus. Scientific Reports. 2020;10(1):7939. doi: 10.1038/s41598-020-64531-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64531-1</ArticleId><ArticleId IdType="pmc">PMC7224179</ArticleId><ArticleId IdType="pubmed">32409751</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AT, Williams AJ, Gary HE Jr., Pallansch MA, Wassilak SG, Oberste MS. Effect of time at temperature on wild poliovirus titers in stool specimens. Virology. 2015;482:28–31. Epub 2015/03/31. doi: 10.1016/j.virol.2015.03.005 ; PubMed Central PMCID: PMC4620922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.03.005</ArticleId><ArticleId IdType="pmc">PMC4620922</ArticleId><ArticleId IdType="pubmed">25817402</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes E, Diop O, Jorba J, Chavan S, Tangermann R, Wassilak S. Surveillance Systems to Track Progress Toward Polio Eradication—Worldwide, 2015–2016. 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657908</ArticleId><ArticleId IdType="pubmed">28384129</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO lists two COVID-19 tests for emergency use [webpage]. 2020 [updated 7 April 2020; cited 2020 October 20]. Available from: https://www.who.int/diagnostics_laboratory/eul_0504-046-00_cobas_sars_cov2_qualitative_assay_ifu.pdf?ua=1.</Citation></Reference><Reference><Citation>Hyypiä T, Hovi T, Knowles NJ, Stanway G. Classification of enteroviruses based on molecular and biological properties. J Gen Virol. 1997;78 (Pt 1):1–11. Epub 1997/01/01. doi: 10.1099/0022-1317-78-1-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-78-1-1</ArticleId><ArticleId IdType="pubmed">9010279</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al.. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798–801. Epub 2009/06/23. doi: 10.1038/nm.1992 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>